SpassageQ
by Spass, Inc.
510(k) K230386
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK230386 | Date15 Jun 2023 | StatusActive |
Official records
- FDA 510(k) database K230386
From the FDA record
- Received by the FDA
- 14 Feb 2023
- FDA decision
- 15 Jun 2023 (Substantially Equivalent)
- FDA review time
- 121 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- PLB
- Device class
- Class II
- Regulation
- 21 CFR Part 870.2300
- Advisory committee
- Cardiovascular
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The SpassageQ is a Multivariate Vital Signs Index device intended for use in cardiovascular applications. It is designed to process patient data from already cleared patient monitoring devices that measure respiratory rate, systolic blood pressure, and Glasgow Coma Scale (GCS).
The device provides a qSOFA score (quickSOFA) to help identify patients with suspected infection who are at greater risk for poor outcomes. It is used in healthcare facilities and was cleared via the FDA 510(k) pathway under K230386, with a traditional clearance decision and classification as a Class II device.
Devices cleared under K230386
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| SpassageQ 1.0.0 | 1.0.0 | 08809957910002 | — | On the market |
Similar devices
Other devices filed under FDA product code PLB (Multivariate Vital Signs Index).